An Act relative to specialty medications and patient safety
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This bill addresses concerns surrounding specialty medications, which are often very expensive, and their impact on patient safety and affordability. It aims to improve transparency and accountability in the pricing and access to these medications. The legislation seeks to ensure patients have clear information about their medication costs and potential alternatives. Ultimately, the goal is to protect patients from unexpected and exorbitant drug expenses.
Key provisions
- Requires manufacturers to provide data on drug pricing and utilization.
- Establishes a process for reviewing and potentially adjusting the prices of specialty medications.
- Promotes the development and use of generic and biosimilar alternatives.
- Enhances patient access to information about medication costs.
- Supports efforts to negotiate lower drug prices.
- Requires reporting on the use of specialty medications.
- Addresses the issue of prior authorization requirements for specialty drugs.
Who is affected
- Patients
- Pharmaceutical manufacturers
- Healthcare providers
- Insurance companies
- The state’s healthcare system
Notable changes
- The bill seeks to increase transparency in specialty drug pricing.
- It may lead to changes in how drug prices are determined and negotiated.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours